Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

Overview of attention for article published in Journal of Hematology & Oncology, April 2012

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,781 followers.

Anorexia/Med: Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients wi... http://t.co/Su1iV2Va

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.